Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
worksSOwell is a health and wellness company specializing in advanced cellular nutrition for both humans and animals. The company's flagship technology, 1-TetraDecanol Complex (1-TDC), is a unique fatty acid complex designed to support joint health, muscle recovery, and periodontal health. Unlike traditional supplements like glucosamine or fish oil, 1-TDC acts as a cellular lubricant that provides rapid localized support for inflammatory conditions. The company markets its products primarily to veterinary professionals, competitive athletes, and pet owners seeking high-performance recovery solutions. Their product line includes specialized formulations for canine, feline, and human applications, emphasizing science-backed results in mobility and oral health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on worksSOwell.